Atripla (generic name: efavirenz / emtricitabine / tenofovir disoproxil fumarate) is a combination medicine used alone or with other medicines to treat HIV-1 infection in adults.
Atripla combines two nucleoside reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor (NNRTI) in one pill.
With the power of three HIV medicines in one pill, you may only need to take one Atripla pill each day. For many patients, Atripla offers a complete HIV regimen in a single daily dose.
Atripla helps block HIV-1 reverse transcriptase, a viral chemical in your body (enzyme) that is needed for HIV-1 to multiply. Atripla lowers the amount of HIV-1 in the blood (viral load).
Atripla may also help to increase the number of T cells (CD4+ cells), allowing your immune system to improve. Lowering the amount of HIV-1 in the blood lowers the chance of death or infections that happen when your immune system is weak (opportunistic infections).the amount of didanosine in your blood, which could result in more side effects.